Patents by Inventor Sharon Davis Boggs

Sharon Davis Boggs has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CHEMICAL COMPOUNDS
    Publication number: 20100280010
    Abstract: The present invention provides compounds that demonstrate protective effects on target cells from HIV infection in a manner as to bind to chemokine receptor, and which affect the binding of the natural ligand or chemokine to a receptor such as CXCR4 of a target cell.
    Type: Application
    Filed: January 24, 2007
    Publication date: November 4, 2010
    Inventors: Kristjan Gudmundsson, Sharon Davis Boggs, John Franklin Miller, Angilique Christina Svolto
  • Chemical compounds
    Patent number: 7622494
    Abstract: The present invention relates to compounds that are useful in the treatment of human papillomaviruses, and also to the methods for the making and use of such compounds.
    Type: Grant
    Filed: June 7, 2004
    Date of Patent: November 24, 2009
    Assignee: SmithKline Beecham Corporation
    Inventors: Sharon Davis Boggs, John G Catalano, Kristjan S Gudmundsson, Leah D'Aurora Richardson, Paul Richard Sebahar
  • Purine derivatives as liver X receptor agonists
    Patent number: 7495004
    Abstract: The invention relates to methods for the treatment or prevention of an LXR mediated disease or condition, including cardiovascular disease and atherosclerosis, novel compounds of formula (I) for use in such methods and pharmaceutical compositions comprising compounds for use in such methods.
    Type: Grant
    Filed: May 20, 2003
    Date of Patent: February 24, 2009
    Assignee: Glaxo Group Limited
    Inventors: Sharon Davis Boggs, Jon Loren Collins, Adam Fivush, Eugene Lee Stewart, Timothy Mark Willson
  • Chemical Compounds
    Publication number: 20080234318
    Abstract: The present invention provides compounds that demonstrate protective effects on target cells from HIV infection in a manner as to bind to chemokine receptor, and which affect the binding of the natural ligand or chemokine to a receptor such as CXCR4 of a target cell.
    Type: Application
    Filed: August 30, 2006
    Publication date: September 25, 2008
    Inventors: Kristjan Gudmundsson, Sharon Davis Boggs
  • Tetrahydrocarbazole derivatives and their pharmaceutical use
    Patent number: 7419997
    Abstract: The present invention relates to novel compounds that are useful in the treatment of human papillomaviruses, and also to the methods for the making and use of such compounds.
    Type: Grant
    Filed: June 7, 2004
    Date of Patent: September 2, 2008
    Assignee: SmithKline Beecham Corporation
    Inventors: Sharon Davis Boggs, Kristjan S Gudmundsson
  • Chemical Compounds
    Publication number: 20080171740
    Abstract: The present invention provides novel compounds that demonstrate protective effects on target cells from HIV infection in a manner as to bind to a chemokine receptor, and which affect the binding of a natural ligand or chemokine to a receptor, such as CXCR4 of a target cell.
    Type: Application
    Filed: September 23, 2005
    Publication date: July 17, 2008
    Applicant: SMITHKLINE BEECHAM CORPORATION
    Inventors: Kristjan Gudmundsson, Sharon Davis Boggs
  • Tetrahydrocarbazole derivatives and their pharmaceutical use
    Patent number: 7351733
    Abstract: The present invention relates to novel compounds that are useful in the treatment of human papillomaviruses, and also to the methods for the making and use of such compounds.
    Type: Grant
    Filed: June 7, 2004
    Date of Patent: April 1, 2008
    Assignee: SmithKline Beecham Corporation
    Inventors: Sharon Davis Boggs, Kristjan S Gudmundsson, Leah D'Aurora Richardson, Paul Richard Sebahar